Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Hamilton

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2003
Accuracy of home blood glucose monitors using forearm blood samples: FreeStyle versus One Touch UltraJason Demers, Michael P Kane, Gary Bakst, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|October 8, 2014
A clinical perspective of canagliflozin in the management of type 2 diabetes mellitusAnneMarie Nardolillo, Michael P Kane, Robert S Busch, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 20, 2006
Precision and accuracy of two blood glucose meters: FreeStyle Flash versus One Touch UltraShannon M Rivers, Michael P Kane, Gary Bakst, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 27, 2015
SGLT-2 INHIBITOR THERAPY ADDED TO GLP-1 AGONIST THERAPY IN THE MANAGEMENT OF T2DMRachel M Saroka, Michael P Kane, Robert S Busch, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 16, 2007
Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intoleranceShannon M Rivers, Michael P Kane, Robert S Busch, et al.
Plos One|July 27, 2016
A Selective Irreversible Inhibitor of Furin Does Not Prevent Pseudomonas Aeruginosa Exotoxin A-Induced Airway Epithelial CytotoxicityTimothy E G Ferguson, James A Reihill, Brian Walker, et al.
World Neurosurgery|February 25, 2019
Dasatinib Reinitiation After Poststroke Thrombolysis Associated with Symptomatic Intracerebral HemorrhageRobert A Hamilton, Mausaminben Hathidara, Syeda Dania Shujaat, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 27, 2004
Conforming to HIPAA regulations and compilation of research dataSteven L Clause, Darren M Triller, Colleen P H Bornhorst, et al.
Diabetes Technology & Therapeutics|February 12, 2008
A glucose meter accuracy and precision comparison: the FreeStyle Flash Versus the Accu-Chek Advantage, Accu-Chek Compact Plus, Ascensia Contour, and the BD LogicLinda E Thomas, Michael P Kane, Gary Bakst, et al.
Diabetes Technology & Therapeutics|September 22, 2009
Accuracy and precision of four value-added blood glucose meters: the Abbott Optium, the DDI Prodigy, the HDI True Track, and the HypoGuard Assure ProCatherine A Sheffield, Michael P Kane, Gary Bakst, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2003
Accuracy of home blood glucose monitors using forearm blood samples: FreeStyle versus One Touch UltraJason Demers, Michael P Kane, Gary Bakst, et al.
Clinical Medicine Insights. Endocrinology and Diabetes|October 8, 2014
A clinical perspective of canagliflozin in the management of type 2 diabetes mellitusAnneMarie Nardolillo, Michael P Kane, Robert S Busch, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 20, 2006
Precision and accuracy of two blood glucose meters: FreeStyle Flash versus One Touch UltraShannon M Rivers, Michael P Kane, Gary Bakst, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 27, 2015
SGLT-2 INHIBITOR THERAPY ADDED TO GLP-1 AGONIST THERAPY IN THE MANAGEMENT OF T2DMRachel M Saroka, Michael P Kane, Robert S Busch, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 16, 2007
Colesevelam hydrochloride-ezetimibe combination lipid-lowering therapy in patients with diabetes or metabolic syndrome and a history of statin intoleranceShannon M Rivers, Michael P Kane, Robert S Busch, et al.
Plos One|July 27, 2016
A Selective Irreversible Inhibitor of Furin Does Not Prevent Pseudomonas Aeruginosa Exotoxin A-Induced Airway Epithelial CytotoxicityTimothy E G Ferguson, James A Reihill, Brian Walker, et al.
World Neurosurgery|February 25, 2019
Dasatinib Reinitiation After Poststroke Thrombolysis Associated with Symptomatic Intracerebral HemorrhageRobert A Hamilton, Mausaminben Hathidara, Syeda Dania Shujaat, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 27, 2004
Conforming to HIPAA regulations and compilation of research dataSteven L Clause, Darren M Triller, Colleen P H Bornhorst, et al.
Diabetes Technology & Therapeutics|February 12, 2008
A glucose meter accuracy and precision comparison: the FreeStyle Flash Versus the Accu-Chek Advantage, Accu-Chek Compact Plus, Ascensia Contour, and the BD LogicLinda E Thomas, Michael P Kane, Gary Bakst, et al.
Diabetes Technology & Therapeutics|September 22, 2009
Accuracy and precision of four value-added blood glucose meters: the Abbott Optium, the DDI Prodigy, the HDI True Track, and the HypoGuard Assure ProCatherine A Sheffield, Michael P Kane, Gary Bakst, et al.
Pageof 3